SCHEMBL6828367

SCHEMBL6828367

O=P(O)(OCCC1CCCCC1)OCCC1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.47
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
CA9 Q16790 1/20 0.40
EPHX1 P07099 2/20 0.38
SRC P12931 1/20 0.37
NFE2L2 Q16236 1/20 0.37
HPGD P15428 1/20 0.36
CYP1A2 P05177 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
S1PR4 O95977 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
S1PR5 Q9H228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6241300 0.87 METAP1 (0.38) METAP1CA12CA1CA2MMP1
SCHEMBL15259065 0.86 METAP1 (0.40) METAP1CA12CA1CA2MMP1
SCHEMBL778682 0.84 METAP1 (0.44) METAP1CA12CA1CA2MMP1
SCHEMBL778639 0.82 METAP1 (0.43) METAP1CA12CA1CA2MMP1
SCHEMBL779606 0.82 METAP1 (0.43) METAP1CA12CA1CA2MMP1
SCHEMBL15257421 0.82 METAP1 (0.40) METAP1CA12CA1CA2MMP1
SCHEMBL779643 0.80 METAP1 (0.41) METAP1CA12CA1CA2MMP1
SCHEMBL778683 0.79 CYP1A2 (0.40) METAP1EPHX1NFE2L2HPGDCYP1A2
SCHEMBL779404 0.78 METAP1 (0.40) METAP1CA12CA1CA2MMP1
SCHEMBL19654946 0.78 BTN3A1 (0.32) METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389624-A1 Phosphorous-containing cysteine and serine protease inhibitors CEPHALON, INC. (US) 2004-02-18 EP disclosed
EP-0871454-B1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON INC (US) 2003-11-12 EP disclosed
EP-0871454-A4 1998-11-25 EP disclosed
EP-0871454-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1998-10-21 EP disclosed
US-5639732-A FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT CEPHALON, INC. (US) 1997-06-17 US disclosed
WO-1997003679-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1997-02-06 WO disclosed